bosentan anhydrous has been researched along with Coronary Artery Vasospasm in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aykan, AC; Celik, S; Gökdeniz, T; Gül, I | 1 |
| Kamphuisen, PW; Raijmakers, PG; Vermeltfoort, IA | 1 |
| Fisher, M; Krishnan, U; Win, W | 1 |
3 other study(ies) available for bosentan anhydrous and Coronary Artery Vasospasm
| Article | Year |
|---|---|
A new hope in the treatment of coronary vasospasm: bosentan.
Topics: Aged; Bosentan; Coronary Vasospasm; Endothelin Receptor Antagonists; Humans; Male; Sulfonamides | 2013 |
Improved myocardial perfusion preceding clinical response on bosentan treatment for coronary vasospasm.
Topics: Angina Pectoris, Variant; Antihypertensive Agents; Blood Flow Velocity; Bosentan; Coronary Vasospasm; Fractional Flow Reserve, Myocardial; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Positron-Emission Tomography; Sulfonamides | 2009 |
First report of the successful use of bosentan in refractory vasospastic angina.
Topics: Angina Pectoris, Variant; Antihypertensive Agents; Bosentan; Coronary Vasospasm; Endothelins; Female; Humans; Middle Aged; Sulfonamides; Treatment Outcome | 2010 |